ANE:BMECorporacion Acciona Energias Renovables SA Analysis
Data as of 2026-03-17 - not real-time
$135.35
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Arista Networks posted a robust Q4 with revenue up 28.9% YoY and net income surpassing $950 million, underscoring its strong foothold in AI‑driven data center networking. Operating margins above 41% and a free cash flow generation of roughly $3.4 billion highlight exceptional profitability and balance sheet strength, with cash exceeding $10 billion and minimal debt. Technical signals are mixed: the MACD histogram is bullish while the 20‑day SMA sits just below the current price, and the RSI hovers around the neutral 50 mark, suggesting limited short‑term momentum. However, the stock trades at a price well above the DCF‑derived fair value of $108 and carries a PE of nearly 48×, markedly higher than the industry average, indicating a valuation premium. The high beta of 1.56 and 30‑day volatility over 55% flag elevated market risk, yet the company’s growth trajectory in AI Ethernet and its cash‑rich position provide a solid defensive cushion. Investors should weigh the strong earnings momentum against the overvalued pricing and heightened volatility when deciding on entry points.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram indicating short‑term upside potential
- Current price near the upper end of the recent trading range
- Decreasing volume trend suggesting waning buying pressure
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained revenue growth of ~29% driven by AI networking demand
- Strong cash generation and minimal debt providing financial flexibility
- Forward PE compression to ~32× as earnings are expected to accelerate
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic positioning in the expanding AI‑centric data‑center market
- High ROE (~31%) and robust free cash flow supporting reinvestment
- Potential valuation correction aligning price with intrinsic fair value over time
Key Metrics & Analysis
Financial Health
Revenue Growth28.90%
Profit Margin38.99%
P/E Ratio48.5
ROE31.40%
ROA14.39%
Debt/Equity0.18
P/B Ratio13.7
Op. Cash Flow$4.4B
Free Cash Flow$3.4B
Industry P/E34.2
Technical Analysis
TrendNeutral
RSI50.4
Support$122.37
Resistance$145.00
MA 20$134.20
MA 50$134.79
MA 200$129.28
MACDBullish
VolumeDecreasing
Fear & Greed Index79.45
Valuation
Fair Value$108.66
Target Price$177.74
Upside/Downside31.32%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.56
Volatility55.30%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.